ARS Pharmaceuticals

ARS Pharmaceuticals

Yahoo Finance • 15 days ago

At a glance: stocks gapping down premarket

[Wall Street-Street Sign] P_Wei/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell on Friday. Stock index futures were muted on Friday after the S&P 500 closed at a record high in the pre... Full story

Yahoo Finance • 19 days ago

SPRY DEADLINE: Levi & Korsinsky Reminds ARS Pharmaceuticals Inc. Investors of Upcoming Securities Class Action Deadline

NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities of a pending securities class action brought on behalf of investors who acquired shares between Ma... Full story

Yahoo Finance • 19 days ago

SPRY Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ARS Pharmaceuticals Inc. Securities Class Action

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities... Full story

Yahoo Finance • 23 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of ARS Pharmaceuticals, Inc. Securities and Sets a Lead Plaintiff Deadline of October 5, 2026

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ARS Pharmaceuticals, Inc. (“ARS” or the “Company... Full story

Yahoo Finance • last month

ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) is one of the 10 best stocks under $10 that could triple. On July 8, ARS Pharmaceuticals Inc. (NASDAQ:SPRY) disclosed a CEO transition, and effective July 6, the company's Co-founder and Chief Execut... Full story

Yahoo Finance • 2 months ago

Micron Sparks Fresh AI Stock Rally

This article first appeared on GuruFocus. U.S. stock futures edged higher Thursday as Micron (NASDAQ:MU) gave investors exactly what they wanted: a huge AI memory report and stronger guidance. Micron jumped about 17% after its fiscal Q3... Full story

Yahoo Finance • 2 months ago

Biggest stock movers Thursday: AI chip stocks, WEN, SPRY, and more

[Analyzing Business Performance Through Data Analytics] U.S. stock futures edged higher on Thursday, supported by a stellar earnings report from Micron Technology, as markets turned their focus to the release of key May inflation data for... Full story

Yahoo Finance • 3 months ago

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

Earnings Call Insights: ARS Pharmaceuticals (SPRY) Q1 2026 MANAGEMENT VIEW * “We are off to a strong start in 2026... building momentum across the business,” said (Co-Founder, President, CEO & Director Richard Lowenthal), highlighting... Full story

Yahoo Finance • 3 months ago

ARS Pharma (SPRY) Q4 2025 Earnings Transcript

Image source: The Motley Fool. DATE Monday, March 9, 2026, at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Richard LowenthalChief Commercial Officer — Eric KarasChief Financial Officer — Kathleen Scott Need a quote from a... Full story

Yahoo Finance • 3 months ago

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index falling 1.1% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

ARS Pharmaceuticals Q1 Earnings Call Highlights

Key Points Interested in ARS Pharmaceuticals, Inc.? Here are five stocks we like better. ARS Pharmaceuticals reported $22.7 million in first-quarter 2026 revenue, with U.S. net product revenue for neffy reaching $17.5 million as prescript... Full story

Yahoo Finance • 3 months ago

ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

Q1 2026 total revenue of $22.7 million including neffy® (epinephrine nasal spray)U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive update anticipated in early June Sales for... Full story

Yahoo Finance • 3 months ago

Here are the major earnings before the open Friday

Major earnings expected before the bell on Friday include: * Sachem Capital Corp. (SACH [https://seekingalpha.com/symbol/SACH]) * Mizuho Financial Group (MFG [https://seekingalpha.com/symbol/MFG]) * Datavault AI (DVLT [https://seeki... Full story

Yahoo Finance • 4 months ago

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results

SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could... Full story

Yahoo Finance • 4 months ago

Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver

We recently compiled a list of the 10 Best Biotech Stocks Under $10 to Buy. ARS Pharmaceuticals, Inc. is another best biotech stock under $10 to buy. TheFly reported on April 9 that Northland initiated coverage of SPRY with an Outperform... Full story

Yahoo Finance • 4 months ago

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

neffy offers a new delivery method for epinephrine in Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to market neffy in Canada, expects availability in the summer o... Full story

Yahoo Finance • 6 months ago

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * 3D Systems Corporation (DDD [https://seekingalpha.com/symbol/DDD]) * FuelCell Energy (FCEL [https://seekingalpha.com/symbol/FCEL]) * Zim Integrated Shipping Services Ltd.... Full story

Yahoo Finance • 6 months ago

Dan Loeb's Third Point takes new stake in Chipotle Mexican Grill, Alibaba in Q4 moves

Dan Loeb's Third Point took new stakes in Chipotle Mexican Grill (CMG [https://seekingalpha.com/symbol/CMG]), Alibaba (BABA [https://seekingalpha.com/symbol/BABA]), and Spotify (SPOT [https://seekingalpha.com/symbol/SPOT]), while increasin... Full story

Yahoo Finance • 6 months ago

Got $300? 2 Biotech Stocks to Buy and Hold Forever

Krystal Biotech(NASDAQ: KRYS) and ARS Pharmaceuticals(NASDAQ: SPRY) have been gaining a lot of attention over the past year, thanks to the potential in their groundbreaking -- and for now, only -- commercial therapies. In 2023, Krystal pi... Full story

Yahoo Finance • 8 months ago

neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)

ARS Pharmaceuticals, Inc. neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a license from... Full story